Skip to content
Search

Latest Stories

New funding contract ‘not enough’ to release the sector from financial blackhole

The £3 billion pharmacy funding package falls £1.99 billion short of the estimated full cost of NHS pharmacy services.

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.


As part of the deal, the government also agreed to a write-off of historic margin overspend, with £193 million being written off, and a commitment to reviewing margin distribution.

Despite community pharmacy receiving the largest funding uplift in the NHS, many within the sector argue that the increase falls short of the findings of the recent economic review, which concluded that 78% of pharmacies in England are “unsustainable in the short run.”

“While the announcement is a step forward, set against the backdrop of the economic analysis, you can’t help but argue that it’s just not enough to help community pharmacy release itself from the financial blackhole it has been placed in,” said Louise Laban, sales and marketing director, at Centred Solutions.

She emphasised that community pharmacy has been operating at a significant loss for several years, a fact confirmed by the economic analysis of NHS pharmacy services.

The review found that almost half of pharmacies did not make a profit last year, and 99% of pharmacies had funding which was lower than the full economic cost.

It also estimated that community pharmacy costs could rise from £5,063 million to £8,106 million between 2023/24 and 2029/30.

“While you could argue that having a contract in place means that community pharmacy contractors finally know what to expect and are no longer operating in the dark, it’s fair to say that the deal agreed is simply not enough,” Laban said.

The biggest uplift in the agreement was seen in the Single Activity Fee (SAF), increasing by 19p to £1.46 per item from 1st April.

However, Laban agreed with others in the sector that this increase will likely be absorbed by the National Living Wage and National Insurance increases.

“The economic analysis estimated the full economic cost of NHS services to be £5.063bn while the amount agreed for this year’s contract is just £3.073bn. That is a shortfall of £1.990 billion,” she explained.

Funding alone won’t save pharmacy

Now, the key question is whether this funding will be enough to sustain the sector while negotiations begin for the 2026/27 contract.

Laban said: “The answer could lie in how community pharmacies respond to the hand they have been so badly dealt. It is clear that funding alone isn’t going to be enough to save community pharmacy.”

“What is needed is a combination of funding and reform.”

She encourages pharmacies to embrace new opportunities and ways of working, including delivering private services, which are “far more profitable than NHS services.”

Additionally, she said pharmacies should streamline dispensing service while maintaining or and even increasing, item volumes.

“This will ensure that pharmacy has more capacity to deliver services,” Laban stated.

However, she acknowledged that community pharmacy needs support to fully embrace these opportunities.

She stressed the need for collaboration with technology providers and for the government to move ahead quickly with the reforms they have promised – particularly hub and spoke between different legal entities and supervision changes to give Accredited Checking Technicians (ACTs) more responsibility.

Last week, pharmacy minister Stephen Kinnock confirmed that changes to legislation will be made in the coming weeks, with the first model of hub-and-spoke dispensing expected to be introduced later this year.

Laban described the new funding agreement as “simply the first step in uplifting pharmacy cashflow” and urged the government to commit to increasing funding further to undo the damage of the past 10 years when negotiations for the 2026/27 contract begin.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less